Related Experiment Video
Updated: Feb 14, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
Stable Liquid Glucagon: Beyond Emergency Hypoglycemia Rescue
Leah M Wilson1, Jessica R Castle1
11 Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, Portland, OR, USA.
Stable liquid glucagon is needed for type 1 diabetes management. Improved formulations will enhance treatment for hypoglycemia and support advanced diabetes technologies, improving patient quality of life.
Area of Science:
- Endocrinology and Metabolism
- Pharmaceutical Sciences
Background:
- Glycemic control is crucial for preventing diabetes complications but increases hypoglycemia risk.
- Severe hypoglycemia significantly impairs quality of life and can be fatal for type 1 diabetes patients.
- Current glucagon emergency kits are effective but complex for untrained users.
Purpose of the Study:
- To review current and upcoming pharmaceutical uses of glucagon in type 1 diabetes treatment.
- To highlight the need for stable liquid glucagon formulations.
- To discuss the potential benefits of stable liquid glucagon for various hypoglycemia treatments.
Main Methods:
- Literature review of pharmaceutical uses of glucagon.
- Analysis of existing glucagon delivery devices and formulations.
- Discussion of future directions for stable liquid glucagon development.
Main Results:
- Existing glucagon emergency kits present usability challenges.
- A stable liquid glucagon formulation is lacking despite advances in insulin.
- Stable liquid glucagon could enable wider use of mini-dose glucagon and closed-loop systems.
Conclusions:
- There is a significant need for stable liquid glucagon preparations.
- Availability of stable liquid glucagon would improve hypoglycemia management in type 1 diabetes.
- Future research and development should focus on creating stable liquid glucagon for patient use.
Related Concept Videos
Hypoglycemia and Glucagon
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Emerging Adulthood
Introduction Cardiac Emergencies
Applications of GIS: Disaster Management and Emergency Response
Molecular Comparison of Gases, Liquids, and Solids

